Skip to main content

Point72 Asset Management, L.P.

Position in CELC — Celcuity Inc.

CIK 1603466 STAMFORD, CT

Position in CELC

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$31,996,181
+$31,996,181 QoQ
Shares Held
280,324
Ownership
0.575%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
4 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in CELC Over Time

Shares Held

Position Value (USD)

Derivatives in CELC

reported options exposure · as of Mar 31, 2026
CallValue
$1,563,718
CallShares
13,700
PutValue
$2,967,640
PutShares
26,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $2,392,275,927 across 187 Biotechnology names. CELC ranks #23 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CELC

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,563,718 13,700
2026-03-31 $2,967,640 26,000
2026-03-31 $31,996,181 280,324
2025-12-31 $239,376 2,400
2025-09-30 $326,040 6,600
2024-06-30 $951,301 58,077